BioNxt Solutions

BioNxt Solutions PP&E per Employee

PP&E per Employee of BioNxt Solutions (BNXT.CN) as of Oct 18, 2026.

PP&E per Employee

-CAD

Last updated:

PP&E per Employee of BioNxt Solutions is 2026 - CAD. PP&E per Employee of BioNxt Solutions was 2025 - CAD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioNxt Solutions Stock analysis

What does BioNxt Solutions do? BioNxt Solutions Inc, based in Vancouver, Canada, operates in the Health Care sector, specifically within Pharmaceuticals. The company produces, extracts, and sells medical cannabis, with a focus on drug formulations, delivery systems, and diagnostic screening tests. It has R&D operations in North America and Europe, emphasizing Germany, and targets regulatory approval and commercialization of medical products for European markets. Through its subsidiary 3a-diagnostics GmbH, it offers diagnostic products including a COVID-19 PCR kit and an oral biosensor for peri-implantitis. BioNxt Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNxt Solutions stock

On Eulerpool you can find the complete historical development of PP&E per Employee BioNxt Solutions since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's BioNxt Solutions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — BioNxt Solutions

All Key Metrics — BioNxt Solutions